Skip to main content
. 2011 Dec 20;52(13):9567–9572. doi: 10.1167/iovs.11-8171

Figure 2.

Figure 2.

Imaging of luminescence (A) at the site of injection of AAV2 in Balb/c mouse after 14 days (LG) with microsyringe; (B) in the abdominal area of mouse injected with AAV9 after 14 days; (C) facial area with persistent luminescence in mouse injected with AAV5 after LG removal at Day 30; (D) corneal luminescence 24 hours after topical AAV9 application (2 μL of 5 × 1012 particles per mL); and (E) comparative measurement of AAV-Luc transduction in vivo in the abdominal area 30 days after injection in LG.